| Name | Title | Contact Details |
|---|
Robinson International Group Limited is a Houston, TX-based company in the Business Services sector.
P C Enterprises Inc is a Kaneohe, HI-based company in the Business Services sector.
Integrity Growth Partners (IGP) is a private equity firm based in Los Angeles, California, established in 2018. The firm specializes in investing in high-growth software and tech-enabled services businesses, particularly in the lower middle market. IGP aims to empower founders by providing flexible capital, helping them accelerate growth and realize their vision. The company emphasizes integrity, growth, and partnership in its approach. IGP supports bootstrapped founders with a collaborative and tailored strategy, ensuring transparency and humility in their interactions. They offer various investment services, including growth capital, de-risking capital, and recapping capital, to businesses poised for the next phase of growth. IGP has made notable investments, such as a $48 million strategic growth investment in CoachCare, a leader in remote patient monitoring and virtual care management.
PIOGA represents nearly 350 members, including oil and natural gas producers, drilling contractors, service companies, manufacturers, distributors, professional firms and consultants, pipelines, end users, royalty owners, and others with interests in the success of Pennsylvanias oil and gas industry. PIOGA member companies drill and operate the majority of the states crude oil and natural gas wells, including those targeting the Marcellus and Utica Shale.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.